Propel Bio Management »

Kyverna Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.3M 667k 9.40

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Miragen Therapeutics (VRDN)
Milestone Pharmaceuticals (MIST)
Kyverna Therapeutics (KYTX)
Compass Pathways Sponsored Ads (CMPS)
Inventiva Sa - Ads (IVA)
Delcath Systems Com New (DCTH)
Abeona Therapeutics Com New (ABEO)
Celldex Therapeutics Com New (CLDX)
Nektar Therapeutics Com New (NKTR)
Oculis Holding Ordinary Shares (OCS)
Sab Biotherapeutics Com New (SABS)
Regenxbio Inc equity us cm (RGNX)

View all positions for Propel Bio Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Catalio Capital Management
Millennium Management
BlackRock
RFG Advisory

View all funds holding Kyverna Therapeutics